Dr. Essam Hamza reports

TREATMENT.COM AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) BOUGHT DEAL PRIVATE PLACEMENT

Treatment.com AI Inc. has entered into an agreement with Ventum Financial Corp., as underwriter and sole bookrunner, in connection with a brokered private placement of six million units of the company at a price of 50 cents per unit for gross proceeds to the company of $3-million.

Each unit will consist of one common share in the capital of the company and one-half of one common share purchase warrant of the company. Each warrant will entitle the holder thereof to purchase one common share of the company for a period of 24 months following the closing date (as hereinafter defined) at an exercise price of 75 cents per warrant share.

The offering is being completed pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 (Prospectus Exemptions) to purchasers resident in each of the provinces of Canada, except Quebec. The units issued pursuant to the offering will not be subject to a hold period in accordance with applicable Canadian securities laws. There is an offering document related to the offering that can be viewed under the company's profile at SEDAR+ and on the company's website. Prospective investors should read this offering document before making an investment decision.

Upon closing of the offering, the company will: (i) pay to the underwriter a cash fee equal to 8.0 per cent of the aggregate gross proceeds of the offering; and (ii) issue to the underwriter warrants of the company exercisable at any time prior to the date that is 24 months from the closing date to acquire that number of units equal to 8.0 per cent of the number of units issued under the offering, at an exercise price equal to the offering price, subject to adjustment in certain events.

The company intends to use the proceeds raised from the offering for research and development, sales and general and administrative expenses, and working capital. The offering may close in tranches. The offering is expected to close on or before March 12, 2025. The offering is subject to certain conditions, including, but not limited to, receipt of all necessary approvals, including the approval of the Canadian Securities Exchange.

About Treatment.com AI Inc.

Treatment.com AI is a company utilizing artificial intelligence and best clinical practices to positively improve the health care sector and impact current inefficiencies and challenges. With the input of hundreds of health care professionals globally, Treatment has built a comprehensive, personalized health care AI engine, the global library of medicine. With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all health care professionals, as well as providing recommended tests (physical and lab), X-rays and billing codes. The GLM helps health care professionals (doctor, nurse or pharmacist) reduce their administrative burden and create more time for needed face-to-face patient appointments, and enables greater consistency in quality of patient support. Treatment's GLM platform, through supporting health care professionals, allows for the inclusion of disenfranchised communities.

We seek Safe Harbor.